高反应者不孕治疗中临床体外成熟方案结局的系统综述
本系统综述纳入3项前瞻性研究,比较体外成熟(IVM)与常规卵巢刺激(COS)在高反应预测女性中的有效性和安全性。IVM后活产率未显著低于COS(总体OR 0.56,95%CI 0.32-1.01),多数研究未发现产科或围产期并发症率显著差异,但IVM组妊娠期高血压疾病率可能更高。
要点
- IVM后活产率未显著低于COS,总体OR 0.56(95%CI 0.32-1.01)。
- hCG触发IVM的活产OR 0.83(95%CI 0.63-1.10),非hCG触发IVM为0.45(95%CI 0.18-1.13)。
- 多数研究未发现IVM与COS在产科或围产期并发症率上有显著差异,但IVM组妊娠期高血压疾病率可能更高。
核心结论
- IVM后活产率未显著低于COS,总体OR 0.56(95%CI 0.32-1.01),无论移植胚胎阶段如何。
- 多数研究未发现IVM与COS在产科或围产期并发症率上有显著差异,但IVM组妊娠期高血压疾病率可能更高。
- IVM与COS后经体外受精或卵胞浆内单精子注射的子代发育似乎相似。
- 需要进一步研究以确定哪些患者人群将从IVM中获益最大、定义合适的临床方案并开发最佳培养系统。
研究设计与样本
- 系统综述,纳入3项符合条件的前瞻性研究,比较任何IVM方案与任何COS方案后行体外受精或卵胞浆内单精子注射。
主要发现
- IVM后活产率未显著低于COS,总体OR 0.56(95%CI 0.32-1.01)。
- hCG触发IVM的活产OR 0.83(95%CI 0.63-1.10),非hCG触发IVM为0.45(95%CI 0.18-1.13)。
- 非随机研究数据显示IVM与COS相比活产率或显著较低或统计学相当。
- 多数研究未发现IVM与COS在产科或围产期并发症率上有显著差异,但IVM组妊娠期高血压疾病率可能更高。
- IVM与COS后经体外受精或卵胞浆内单精子注射的子代发育似乎相似。
局限性
- 需要进一步研究以确定哪些患者人群将从IVM中获益最大、定义合适的临床方案并开发最佳培养系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Oocyte in vitro maturation (IVM) has been proposed as an alternative to conventional ovarian stimulation (COS) in subfertile women with polycystic ovary syndrome. To evaluate the effectiveness and safety of IVM compared with COS in women with predicted hyperresponse to gonadotropins, we searched the published literature for relevant studies comparing any IVM protocol with any COS protocol followed by in vitro fertilization or intracytoplasmic sperm injection. A systematic review was undertaken on 3 eligible prospective studies. Live birth rate was not significantly lower after IVM vs. COS (odds ratio [95% confidence interval] of 0.56 [0.32-1.01] overall, 0.83 [0.63-1.10] for human chorionic gonadotropin (hCG)-triggered IVM [hCG-IVM] and 0.45 [0.18-1.13] for non-hCG-triggered IVM [non-hCG-IVM]), irrespective of the stage of transferred embryos. Data from nonrandomized studies generally showed either significantly low or statistically comparable rates of live birth with IVM vs. COS. Most studies have not identified any significant difference between IVM and COS with respect to the rates of obstetric or perinatal complications, apart from a potentially higher rate of hypertensive disorders during pregnancy. The development of offspring from IVM and COS with in vitro fertilization or intracytoplasmic sperm injection appears to be similar. Additional research is needed to identify which patient populations will benefit most from IVM, to define the appropriate clinical protocol, and to develop the optimal culture system.
引用
- Vuong LN, Pham TD, Ho TM, et al. Outcomes of clinical in vitro maturation programs for treating infertility in hyper responders: a systematic review. Fertil Steril. 2023. PMID: 36754159. doi:10.1016/j.fertnstert.2023.01.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。